triazoles has been researched along with Colorectal Cancer in 49 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (4.08) | 18.2507 |
| 2000's | 1 (2.04) | 29.6817 |
| 2010's | 30 (61.22) | 24.3611 |
| 2020's | 16 (32.65) | 2.80 |
| Authors | Studies |
|---|---|
| Christgen, S; Kanneganti, TD; Karki, R; Lee, S; Malireddi, RKS; Neale, G; Nguyen, LN; Samir, P; Sharma, BR; Sundaram, B; Vogel, P; Wang, Y; Zheng, M | 1 |
| Alotaibi, F; Halaweish, F; Halaweish, H; Iram, S; Kasten, A; Kyeremateng, J; Ostlund, T | 1 |
| Arango, D; Colaco, A; Fourniols, T; Lopes, A; Maggio, V; Martínez-Barriocanal, Á; Preat, V; Rafael, D; Schwartz, S; Vidal, EG | 1 |
| Chen, H; Gou, H; Huang, D; Kang, W; Kei Wu, WK; Liang, C; Liu, W; Pan, Y; Su, H; Wang, Y; Wong, CC; Xu, H; Yu, J; Zhai, J; Zhang, X; Zhou, Q; Zhou, Y | 1 |
| Cheng, X; Huang, Z; Jin, W; Long, D | 1 |
| Denk, S; Gallant, P; Germer, CT; Kastner, C; Kettler, J; Müller, N; Otto, C; Schmidt, S; Wiegering, A; Wolf, E | 1 |
| Aladhraei, M; Kassem Al-Thobhani, A; Poungvarin, N; Suwannalert, P | 1 |
| Cao, Y; Deng, P; Evers, BM; Guo, Y; He, D; Lee, EY; Liu, S; Morris, AJ; Schwartz, CE; She, QB; Wang, C; Ye, Q; Zaytseva, YY; Zhou, Z | 1 |
| Amberg, S; Bokemeyer, C; Kranich, AL; Mann, J; Nilsson, S; Papadimitriou, K; Rolfo, C; Stein, A; Theile, S | 1 |
| Cho, KH; Lee, HS; Lee, S | 1 |
| Cui, L; Huang, Z; Liu, CY; Wang, Y; Wen, D; Wu, T; Zhu, Z | 1 |
| Ishizuka, S; Kato, Y; Kondo, S; Noguchi, K; Sadaoka, K; Sugimoto, Y; Takahashi, C | 1 |
| Ding, W; Mei, G; Zhang, H | 1 |
| Chen, K; He, L; Hu, W; Lei, L; Li, Y; Lv, Z; Xie, X; Zhou, B; Zhou, Z | 1 |
| Cui, Y; Gao, Q; Li, Y; Liu, S; Sun, Z; Wang, X; Zhang, H; Zhang, S | 1 |
| Barra, G; Belli, V; Blauensteiner, B; Cardone, C; Ciaramella, V; Ciardiello, D; Ciardiello, F; Corte, CD; Cuomo, A; De Falco, V; Franco, R; Giunta, EF; Marino, FZ; Martinelli, E; Martini, G; Matrone, N; Mohr, T; Morgillo, F; Napolitano, S; Poliero, L; Selvaggi, F; Sibilia, M; Troiani, T; Vitiello, PP | 1 |
| Grbčić, P; Kelly, JM; Kraljević Pavelić, S; Racané, L; Radić Stojković, M; Raić-Malić, S; Rep, V; Taylor, MC; Zonjić, I | 1 |
| Han, X; Hu, Z; Li, Z; Wang, Y; Wu, Z; Yan, J; Zheng, Q; Zhu, Q | 1 |
| Chen, W; Cui, L; Du, P; Huang, Y; Huang, Z; Liu, CY; Liu, Y; Wang, G; Wu, T; Yang, Y; Zhu, Z | 1 |
| Assiotis, I; Box, G; Chauhan, R; Cunningham, D; De Haven Brandon, A; Eason, K; Isacke, CM; Jenkins, L; Khan, K; Kirkin, V; Mancusi, C; Manodoro, F; Matthews, N; Robinson, P; Rust, AG; Sadanandam, A; Self, A; Starling, N; Valenti, M; Valeri, N; Vlachogiannis, G; Wagner, S; Whittaker, SR | 1 |
| Kim, DU; Kim, SW; Kwak, B | 1 |
| Beaver, L; Bedford, M; Chang, K; Chen, YS; Dashwood, M; Dashwood, R; Ertem, F; Ho, E; Huang, Y; Johnson, G; Leung, HC; Li, J; Li, L; Lieberman, D; Nguyen, N; Rajendran, P; Sun, D; Ulusan, A; Vilar, E; Wang, S; Zhang, M | 1 |
| Blake, RA; Boggs, J; Callow, M; Chan, E; Choo, E; Costa, M; Diaz, D; Firestein, R; Holsworth, DD; Korinek, V; Krauss, S; Lau, T; Machon, O; Magnuson, S; Merchant, M; Polakis, P; Sambrone, A; Schutten, M; Waaler, J | 1 |
| Diaz, R; El-Hariry, I; El-Rayes, BF; Farris, AB; Ganji, PN; Landry, J; Mahaseth, H; Nagaraju, GP; Park, W; Proia, DA; Sullivan, PS; Taliaferro-Smith, L; Wen, J; Willingham, F | 1 |
| Chen, Z; Hu, J; Hu, Y; Pan, T; Sun, J; Xu, D; Xu, W; Zhang, S; Zheng, S; Zhou, J | 1 |
| Bates, RC; He, S; Proia, DA; Sang, J; Sequeira, M; Smith, DL | 1 |
| Beißbarth, T; Dobbelstein, M; Gaedcke, J; Ghadimi, M; Grade, M; He, S; Kramer, F; Landmann, H; Moll, U; Ogawa, LS; Proia, DA | 1 |
| Alese, OB; Diaz, R; El-Rayes, BF; Landry, J; Nagaraju, GP | 1 |
| Adams, DH; Bicknell, R; Curbishley, SM; Eksteen, B; Hejmadi, RK; Hepburn, E; Ismail, T; Li, KK; Reynolds, GM; Rot, A; Ward, ST; Weston, CJ | 1 |
| Capanu, M; Cercek, A; Chou, JF; Gollub, M; Proia, DA; Raasch, P; Reidy-Lagunes, D; Saltz, LB; Shia, J; Solit, DB; Vakiani, E | 1 |
| Adwan, H; Ansari, S; Berger, MR; Pervaiz, A | 1 |
| Hromas, R; Jaiswal, AS; Jani, J; Law, BK; Narayan, S; Panda, H; Sharma, J | 1 |
| Baryawno, N; Calero, R; Darabi, A; Dyberg, C; Einvik, C; Johnsen, JI; Kogner, P; Kool, M; Milosevic, J; Sandén, E; Siesjö, P; Sveinbjörnsson, B; Wickström, M | 1 |
| Chopra, VS; Firestein, R; Gnad, F; Haley, B; Lorenzana, E; Mayba, O; McCleland, ML; Mesh, K; Segal, E; Watanabe, C; Yaylaoglu, M | 1 |
| Arango, D; Chueh, AC; Dawson, MA; Dhillon, AS; Diez-Dacal, B; Filippakopoulos, P; Gahman, TC; Jayachandran, A; Mariadason, JM; Nightingale, R; Phesse, T; Shiau, AK; Sieber, OM; Tögel, L; Tran, H; Wu, R | 1 |
| Benner, A; Berthel, A; Brand, K; Buechler, MW; Falk, CS; Grabe, N; Halama, N; Herrmann, T; Jaeger, D; Kahlert, C; Klupp, F; Koch, M; Krauss, J; Kunz, C; Lasitschka, F; Lerchl, T; Luckner-Minden, C; Luecke, S; Schneider, M; Springfeld, C; Suarez-Carmona, M; Suetterlin, T; Ulrich, A; Weitz, J; Zitvogel, L; Zoernig, I | 1 |
| Baldassarre, M; Bates, JG; Breckenridge, DG; Calderwood, DA; Chen, F; Kuruvilla, L; Martinez, R; Mihaylova, VT; Schlessinger, J; Shi, X; Sperandio, D; Turk, BE; Viviano, S; Yue, P | 1 |
| Chen, W; Cui, L; Fang, S; Hou, X; Huang, YY; Li, HQ; Liu, CY; Ouyang, X; Wang, G; Wu, T; Yang, Y; Yu, T; Zhong, Y | 1 |
| Pedersen, NM; Stenmark, H; Thorvaldsen, TE; Wenzel, EM | 1 |
| Tang, SC | 1 |
| Dembinski, JL; Dinh, H; Gradl, D; Krauss, S; Lundenes, E; Machon, O; Machonova, O; Paulsen, JE; von Kries, JP; Waaler, J; Wedlich, D; Wilson, SR | 1 |
| Kurumurthy, C; Narsaiah, B; Pamanji, R; Sambasiva Rao, P; Santhosh Kumar, G; Shanthan Rao, P; Veera Swamy, B; Velatooru, LR; Venkateswara Rao, J | 1 |
| Al-awar, R; Alizadeh, S; Aman, A; Attisano, L; Bao, RY; Chau, A; Christova, T; Gronda, M; Hogge, DE; Hurren, R; Isaac, M; Jitkova, Y; Joseph, B; Kasper, J; Miller, BW; Perusini, S; Schimmer, AD; Song, S; Subramaniam, R; Weir, SJ; Wrana, JL | 1 |
| Dobrzanski, P; Hockeimer, W; Lu, LD; O'Kane, TM; Ruggeri, BA; Seavey, MM; Stump, KL; Wallace, NH | 1 |
| Gorthi, G; Johnson, T; Paleja, M; Scott, H | 1 |
| Agrawal, A; Agrawal, DK; Murphy, RF | 1 |
| Clavel, M; Decoster, G; Holdener, EE; Klepp, O; Ludwig, C; Pinedo, HM; Renard, G; Sessa, C; Siegenthaler, P; ten Bokkel Huinink, W | 1 |
3 review(s) available for triazoles and Colorectal Cancer
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
Women and bone health: maximizing the benefits of aromatase inhibitor therapy.
Topics: Anastrozole; Androstadienes; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Breast Neoplasms; Colorectal Neoplasms; Denosumab; Diphosphonates; Female; Humans; Imidazoles; Letrozole; Nitriles; Osteoporosis; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; RANK Ligand; Secondary Prevention; Tamoxifen; Triazoles; Zoledronic Acid | 2010 |
DNA methylation in breast and colorectal cancers.
Topics: Breast Neoplasms; Colorectal Neoplasms; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Humans; Indoles; Male; Phthalimides; Pyridines; Triazoles | 2007 |
5 trial(s) available for triazoles and Colorectal Cancer
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial SENTINEL.
Topics: Active Transport, Cell Nucleus; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Hydrazines; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Oxaliplatin; Prognosis; Survival Rate; Triazoles | 2020 |
Ganetespib, a novel Hsp90 inhibitor in patients with KRAS mutated and wild type, refractory metastatic colorectal cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Colorectal Neoplasms; Drug Resistance, Neoplasm; Female; Follow-Up Studies; HSP90 Heat-Shock Proteins; Humans; Immunoenzyme Techniques; Male; Middle Aged; Mutation; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Salvage Therapy; Survival Rate; Triazoles | 2014 |
Wnt inhibitor screen reveals iron dependence of β-catenin signaling in cancers.
Topics: Acute Disease; Administration, Oral; Benzoates; beta Catenin; Cell Line, Tumor; Cell Proliferation; Ciclopirox; Colorectal Neoplasms; Deferasirox; Deferoxamine; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Hydrazones; Iron; Iron Chelating Agents; Leukemia, Myeloid; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Pyridones; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Wnt Proteins; Wnt Signaling Pathway | 2011 |
Phase II trial of anaxirone (TGU) in advanced colorectal cancer: an EORTC Early Clinical Trials Group (ECTG) study.
Topics: Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Metastasis; Thrombocytopenia; Treatment Outcome; Triazoles | 1994 |
42 other study(ies) available for triazoles and Colorectal Cancer
| Article | Year |
|---|---|
ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis.
Topics: Adenosine Deaminase; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Death; Cell Transformation, Neoplastic; Colorectal Neoplasms; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Hydrazines; Interferon-gamma; Male; Melanoma, Experimental; Mice, Inbred C57BL; Mice, Knockout; Necroptosis; Pyroptosis; Receptor-Interacting Protein Serine-Threonine Kinases; RNA-Binding Proteins; Signal Transduction; Skin Neoplasms; Triazoles | 2021 |
Triazole-estradiol analogs: A potential cancer therapeutic targeting ovarian and colorectal cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; ErbB Receptors; Estradiol; Female; Humans; Molecular Structure; Ovarian Neoplasms; Protein Kinase Inhibitors; Structure-Activity Relationship; Triazoles | 2022 |
Colorectal cancer inhibition by BET inhibitor JQ1 is MYC-independent and not improved by nanoencapsulation.
Topics: Animals; Antineoplastic Agents; Azepines; Cell Line, Tumor; Colorectal Neoplasms; Drug Delivery Systems; Female; Humans; Infusions, Intravenous; Liposomes; Mice; Mice, Inbred BALB C; Nanoparticles; Proteins; Proto-Oncogene Proteins c-myc; Triazoles | 2022 |
METTL3 Inhibits Antitumor Immunity by Targeting m
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Chemokine CXCL1; Colorectal Neoplasms; Cytokines; Humans; Methyltransferases; Mice; Mice, Knockout; Phenylurea Compounds; Receptors, Interleukin-8B; RNA, Guide, Kinetoplastida; Triazoles | 2022 |
BET inhibitor bromosporine enhances 5-FU effect in colorectal cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carbamates; Cell Cycle; Cell Cycle Proteins; Colorectal Neoplasms; Drug Resistance, Neoplasm; Female; Fluorouracil; HCT116 Cells; HT29 Cells; Humans; Mice, Inbred BALB C; Pyridazines; Transcription Factors; Triazoles; Xenograft Model Antitumor Assays | 2020 |
Targeting bromodomain-containing protein 4 (BRD4) inhibits MYC expression in colorectal cancer cells.
Topics: Antineoplastic Agents; Azepines; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Models, Biological; Protein Binding; Proteolysis; Proto-Oncogene Proteins c-myc; Transcription Factors; Transcription, Genetic; Triazoles; Ubiquitin-Protein Ligases | 2019 |
Association of XPO1 Overexpression with NF-κB and Ki67 in Colorectal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Colorectal Neoplasms; Exportin 1 Protein; Female; Follow-Up Studies; HT29 Cells; Humans; Hydrazines; Karyopherins; Ki-67 Antigen; Lymphatic Metastasis; Male; Middle Aged; NF-kappa B; Prognosis; Receptors, Cytoplasmic and Nuclear; Triazoles; Young Adult | 2019 |
Spermine synthase and MYC cooperate to maintain colorectal cancer cell survival by repressing Bim expression.
Topics: Acetylation; Animals; Apoptosis; Azepines; Bcl-2-Like Protein 11; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Down-Regulation; Female; Forkhead Box Protein O3; Gene Deletion; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Nude; MicroRNAs; Models, Biological; Polyamines; Proto-Oncogene Proteins c-myc; Spermine Synthase; Triazoles; Up-Regulation | 2020 |
Cotargeting BET proteins overcomes resistance arising from PI3K/mTOR blockade-induced protumorigenic senescence in colorectal cancer.
Topics: Animals; Azepines; Caco-2 Cells; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Imidazoles; Mice; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinase; Phosphorylation; Proteomics; Quinolines; Signal Transduction; TOR Serine-Threonine Kinases; Triazoles; Xenograft Model Antitumor Assays | 2020 |
Bromodomain and Extraterminal (BET) protein inhibition suppresses tumor progression and inhibits HGF-MET signaling through targeting cancer-associated fibroblasts in colorectal cancer.
Topics: Antineoplastic Agents; Azepines; Cell Cycle; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Drug Screening Assays, Antitumor; Fibroblasts; Hepatocyte Growth Factor; Humans; Proto-Oncogene Proteins c-met; Signal Transduction; Triazoles; Tumor Cells, Cultured | 2020 |
Effect of TNIK upregulation on JQ1-resistant human colorectal cancer HCT116 cells.
Topics: Antineoplastic Agents; Azepines; Colorectal Neoplasms; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; HCT116 Cells; HEK293 Cells; Humans; Protein Serine-Threonine Kinases; Triazoles; Up-Regulation | 2020 |
Synergistic antitumor activity of DHA and JQ1 in colorectal carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Azepines; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Docosahexaenoic Acids; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Mice; NF-kappa B; Proto-Oncogene Proteins c-myc; Transcription Factors; Triazoles; Xenograft Model Antitumor Assays | 2020 |
The bromodomain and extra-terminal domain inhibitor JQ1 synergistically sensitizes human colorectal cancer cells to topoisomerase I inhibitors through repression of Mre11-mediated DNA repair pathway.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Azepines; Camptothecin; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; DNA Repair; Humans; MRE11 Homologue Protein; Topoisomerase I Inhibitors; Triazoles | 2021 |
Oxaliplatin derived monofunctional triazole-containing platinum(II) complex counteracts oxaliplatin-induced drug resistance in colorectal cancer.
Topics: Animals; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Coordination Complexes; DNA; Drug Design; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Glutathione; Humans; Mice; Mice, Nude; Molecular Dynamics Simulation; Nucleic Acid Conformation; Oxaliplatin; Platinum; Triazoles | 2021 |
Dual inhibition of TGFβ and AXL as a novel therapy for human colorectal adenocarcinoma with mesenchymal phenotype.
Topics: Adenocarcinoma; Aged; Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Cell Line, Tumor; Cell Movement; Colorectal Neoplasms; Computational Biology; Databases, Genetic; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Pyrazoles; Quinolines; Receptor Protein-Tyrosine Kinases; Receptor, Transforming Growth Factor-beta Type II; Signal Transduction; Spheroids, Cellular; Triazoles | 2021 |
Synthesis, antiproliferative and antitrypanosomal activities, and DNA binding of novel 6-amidino-2-arylbenzothiazoles.
Topics: Amidines; Antineoplastic Agents; Antiprotozoal Agents; Benzothiazoles; Cell Proliferation; Colorectal Neoplasms; DNA; Drug Evaluation, Preclinical; Humans; Imidazolines; Intercalating Agents; Nucleic Acid Conformation; Structure-Activity Relationship; Triazoles; Trypanosoma brucei brucei | 2021 |
The BET-Bromodomain Inhibitor JQ1 synergized ABT-263 against colorectal cancer cells through suppressing c-Myc-induced miR-1271-5p expression.
Topics: Aniline Compounds; Apoptosis; Azepines; Base Sequence; Cell Line, Tumor; Colorectal Neoplasms; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Sulfonamides; Triazoles | 2017 |
Co-inhibition of BET proteins and NF-κB as a potential therapy for colorectal cancer through synergistic inhibiting MYC and FOXM1 expressions.
Topics: Animals; Antineoplastic Agents; Azepines; Bortezomib; Cell Cycle Checkpoints; Cell Line, Tumor; Colorectal Neoplasms; Drug Synergism; Female; Forkhead Box Protein M1; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; NF-kappa B; Nuclear Proteins; Oncogene Protein p55(v-myc); Proto-Oncogene Proteins c-myc; Triazoles; Xenograft Model Antitumor Assays | 2018 |
Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer.
Topics: Animals; Azepines; Cell Line, Tumor; Colorectal Neoplasms; Drug Resistance, Neoplasm; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Interferons; Mice; Mutation; Organoids; Proto-Oncogene Proteins p21(ras); Pyridones; Pyrimidinones; Triazoles; Xenograft Model Antitumor Assays | 2019 |
Phosphodiesterase 4B is an effective therapeutic target in colorectal cancer.
Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Azepines; Carcinogenesis; Cell Line, Tumor; Colorectal Neoplasms; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Humans; Phosphodiesterase 4 Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Resveratrol; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Triazoles | 2019 |
Acetylation of CCAR2 Establishes a BET/BRD9 Acetyl Switch in Response to Combined Deacetylase and Bromodomain Inhibition.
Topics: Acetylation; Adaptor Proteins, Signal Transducing; Animals; Antineoplastic Combined Chemotherapy Protocols; Azepines; beta Catenin; Cell Line, Tumor; Colorectal Neoplasms; Epigenesis, Genetic; HCT116 Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Isothiocyanates; Male; Mice; Mice, Nude; Proteins; Random Allocation; Sulfoxides; Transcription Factors; Triazoles; Xenograft Model Antitumor Assays | 2019 |
A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.
Topics: Animals; Axin Protein; beta Catenin; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Enzyme Inhibitors; Genes, APC; Humans; Mice; Mutation; Piperidines; Spheroids, Cellular; Sulfones; Tankyrases; Triazoles; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2013 |
Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Tumor; Chick Embryo; Chorioallantoic Membrane; Collagen; Colorectal Neoplasms; Down-Regulation; Drug Combinations; Female; Fibroblast Growth Factor 2; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; HEK293 Cells; HSP90 Heat-Shock Proteins; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Laminin; Mice, Nude; Platelet-Derived Growth Factor; Proteoglycans; Rectal Neoplasms; Ribonuclease, Pancreatic; RNA, Messenger; Specific Pathogen-Free Organisms; STAT3 Transcription Factor; Transforming Growth Factor beta1; Triazoles; Vascular Endothelial Growth Factor A; Vesicular Transport Proteins; Xenograft Model Antitumor Assays | 2013 |
Cytohesins/ARNO: the function in colorectal cancer cells.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Disease Models, Animal; ErbB Receptors; Gene Expression; Gene Knockdown Techniques; GTPase-Activating Proteins; Heterografts; Humans; Male; Mice; Receptor, IGF Type 1; Signal Transduction; Triazoles; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Capecitabine; Cell Cycle; Cell Line, Tumor; Cell Survival; Chemotherapy, Adjuvant; Colorectal Neoplasms; Deoxycytidine; DNA Damage; DNA Repair; Female; Fluorouracil; HCT116 Cells; HSP90 Heat-Shock Proteins; Humans; Mice; Mice, Nude; Radiation-Sensitizing Agents; Radiation, Ionizing; Signal Transduction; Triazoles; Xenograft Model Antitumor Assays | 2014 |
UDP glucuronosyltransferase 1A expression levels determine the response of colorectal cancer cells to the heat shock protein 90 inhibitor ganetespib.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Colorectal Neoplasms; Glucuronosyltransferase; HSP90 Heat-Shock Proteins; Humans; Triazoles | 2014 |
HSP90 inhibition downregulates thymidylate synthase and sensitizes colorectal cancer cell lines to the effect of 5FU-based chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle Proteins; Colorectal Neoplasms; Down-Regulation; Drug Synergism; Female; Fluorouracil; HCT116 Cells; HSP90 Heat-Shock Proteins; HT29 Cells; Humans; Mice; Mice, Nude; Molecular Targeted Therapy; Organoplatinum Compounds; Oxaliplatin; RNA, Small Interfering; Thymidylate Synthase; Transfection; Triazoles; Xenograft Model Antitumor Assays | 2014 |
The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer.
Topics: Animals; Antineoplastic Agents; CCR5 Receptor Antagonists; Cell Line, Tumor; Cell Proliferation; Chemokine CCL4; Chemotaxis, Leukocyte; Colorectal Neoplasms; Cyclohexanes; Drug Screening Assays, Antitumor; Female; Humans; Maraviroc; Melanoma, Experimental; Mice, Inbred BALB C; Neoplasm Transplantation; Receptors, CCR5; T-Lymphocytes, Regulatory; Triazoles | 2015 |
CCR5 blockage by maraviroc induces cytotoxic and apoptotic effects in colorectal cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cyclohexanes; G1 Phase; Humans; Maraviroc; Receptors, CCR5; RNA, Messenger; Signal Transduction; Triazoles | 2015 |
NSC666715 and Its Analogs Inhibit Strand-Displacement Activity of DNA Polymerase β and Potentiate Temozolomide-Induced DNA Damage, Senescence and Apoptosis in Colorectal Cancer Cells.
Topics: Apoptosis; Benzothiazoles; Cell Cycle; Cell Cycle Checkpoints; Cellular Senescence; Colorectal Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Dacarbazine; DNA Damage; DNA Polymerase beta; DNA Repair; Enzyme Inhibitors; HCT116 Cells; Humans; Small Molecule Libraries; Sulfhydryl Compounds; Sulfonamides; Temozolomide; Toluene; Triazoles; Tumor Suppressor Protein p53 | 2015 |
Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance.
Topics: Animals; Antineoplastic Agents; Benzeneacetamides; beta Catenin; Brain Neoplasms; Camptothecin; Celecoxib; Cisplatin; Colorectal Neoplasms; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Doxorubicin; Drug Resistance, Neoplasm; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioma; Glucose-6-Phosphate Isomerase; Heterocyclic Compounds, 3-Ring; Humans; Immunoblotting; Immunohistochemistry; Irinotecan; Medulloblastoma; Mice; Neoplasm Transplantation; Neoplasms; Neuroblastoma; Pyrans; Pyrazines; Pyridines; Real-Time Polymerase Chain Reaction; Sulfones; Temozolomide; Triazoles; Tumor Suppressor Proteins; Vincristine; Wnt Proteins; Wnt Signaling Pathway | 2015 |
CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer.
Topics: Animals; Azepines; Biomarkers, Tumor; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; CpG Islands; DNA Methylation; DNA, Neoplasm; Female; Gene Knockdown Techniques; Humans; Mice; Mice, Nude; Nuclear Proteins; Proto-Oncogene Proteins c-myc; RNA, Long Noncoding; RNA, Neoplasm; Transcription Factors; Triazoles | 2016 |
Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells.
Topics: Animals; Azepines; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Drug Synergism; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; MAP Kinase Signaling System; Mice; Neoplasm Transplantation; Proto-Oncogene Proteins c-myc; Pyridones; Pyrimidinones; Triazoles; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2016 |
Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients.
Topics: Adenocarcinoma; Apoptosis; Chemokine CCL5; Chemokines; Chemotaxis; Clinical Trials, Phase I as Topic; Clodronic Acid; Colorectal Neoplasms; Cyclohexanes; Humans; Interferon-alpha; Liver Neoplasms; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Macrophages; Maraviroc; Molecular Targeted Therapy; Neoplasm Invasiveness; Neoplasm Proteins; NG-Nitroarginine Methyl Ester; Phenylurea Compounds; Pilot Projects; Pyridines; Receptors, CCR5; STAT3 Transcription Factor; Survival Analysis; Triazoles; Tumor Cells, Cultured; Tumor Microenvironment | 2016 |
Loss of TRIM33 causes resistance to BET bromodomain inhibitors through MYC- and TGF-β-dependent mechanisms.
Topics: Azepines; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Drug Resistance; Gene Expression Regulation, Neoplastic; HCT116 Cells; HEK293 Cells; Humans; Molecular Structure; Proteins; Proto-Oncogene Proteins c-myc; Receptors, Transforming Growth Factor beta; RNA Interference; Signal Transduction; Transcription Factors; Transforming Growth Factor beta; Triazoles | 2016 |
Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor.
Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Bortezomib; Cell Line, Tumor; Cell Nucleus; Cell Survival; Colorectal Neoplasms; Drug Synergism; HCT116 Cells; HeLa Cells; Humans; Hydrazines; Mice; Proteasome Inhibitors; Triazoles; Tumor Suppressor Protein p53; Ubiquitination; Xenograft Model Antitumor Assays | 2017 |
Differential Roles of AXIN1 and AXIN2 in Tankyrase Inhibitor-Induced Formation of Degradasomes and β-Catenin Degradation.
Topics: Axin Protein; beta Catenin; Blotting, Western; Cell Line, Tumor; Colorectal Neoplasms; Cytoplasmic Vesicles; Humans; Proteasome Endopeptidase Complex; Proteolysis; Sulfones; Tankyrases; Triazoles; Wnt Signaling Pathway | 2017 |
Novel synthetic antagonists of canonical Wnt signaling inhibit colorectal cancer cell growth.
Topics: Animals; Cell Division; Cell Line, Tumor; Colorectal Neoplasms; Humans; Mice; Oxadiazoles; Signal Transduction; Triazoles; Wnt Proteins | 2011 |
Synthesis of novel alkyltriazole tagged pyrido[2,3-d]pyrimidine derivatives and their anticancer activity.
Topics: Alkylation; Antineoplastic Agents; Azides; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Cyclization; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Leukemia, Monocytic, Acute; Lymphoma; Pyrimidines; Structure-Activity Relationship; Triazoles | 2011 |
Therapeutic efficacy of CEP-33779, a novel selective JAK2 inhibitor, in a mouse model of colitis-induced colorectal cancer.
Topics: Animals; Cell Line, Tumor; Colitis; Colorectal Neoplasms; Disease Models, Animal; Female; Humans; Janus Kinase 2; Mice; Mice, Inbred BALB C; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Triazoles | 2012 |
Rare case of ER positive colorectal stricture demonstrating improvement with letrozole.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Colorectal Neoplasms; Constriction, Pathologic; Female; Humans; Letrozole; Nitriles; Receptors, Estrogen; Triazoles | 2011 |
[Two new therapeutic principles in the management of breast cancer and colorectal cancer: selective oral aromatase inhibition and thymidilate synthase inhibition].
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Colorectal Neoplasms; Enzyme Inhibitors; Female; Humans; Male; Nitriles; Palliative Care; Triazoles | 1997 |